Countries South Korea
SK bioscience Gains Approval for SKYCellflu in Indonesia, Expanding Global Reach for Cell-Cultured Influenza Vaccines
This approval paves the way for exports to the world's fourth most populous country. SK bioscience aims to continue to grow as a global vaccine brand be...
October 23, 2024 | News
Thermo Fisher Concludes Successful Bioprocess World Tour 2024 in APJ, Reigniting Industry Momentum Post-COVID
Thermo Fisher Scientific is proud to announce the successful conclusion of its highly anticipated Bioprocess World Tour 2024 in the Asia-Pacific and Japan ...
October 23, 2024 | News
Angelini Pharma Secures Global and Asia Licensing Option for Brain Health Compound CV-01 in Partnership with Cureverse
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel...
October 23, 2024 | News
Samsung Biologics Inks $1.24 Billion Manufacturing Agreement with Leading Asia Pharma
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced a contract manufacturing deal with an As...
October 23, 2024 | News
South Korea Approves XPOVIO® for Third Indication in Multiple Myeloma Treatment
This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug in South...
October 21, 2024 | News
Antengene’s XPOVIO® Gains Third Approval in South Korea for Multiple Myeloma Treatment
This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug in South...
October 18, 2024 | News
South Korea's Neurophet and AriBio Join Forces to Develop Advanced Diagnostic Platform for Alzheimer's
Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease - Collabor...
October 16, 2024 | News
PharmAbcine Receives Safety Approval for 4mg Dose in Phase 1 Trial of PMC-403, Paving the Way for Multiple Ascending Dose Study
Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascending dose 4 mg cohort. ...
October 15, 2024 | News
CooperVision Announces 4th Asia-Pacific Myopia Management Symposium in Seoul to Tackle Rising Myopia in Children
CooperVision, a global leader in myopia management, is proud to announce the 4th Asia-Pacific Myopia Management Symposium (APMMS) will take ...
October 15, 2024 | News
Samsung Biologics Introduces S-HiCon™ Platform to Optimize High-Concentration Drug Formulations
S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation The platform can address challenges associated...
October 15, 2024 | News
Werfen Becomes First European Partner in Seegene's Technology-Sharing Initiative, Co-Establishing NewCo in Spain
Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene's technol...
October 09, 2024 | News
SK bioscience Invests USD 3 Million in FinaBio to Enhance Next-Generation Conjugate Vaccine Development
SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bio...
October 08, 2024 | News
ABL Bio Partners with MSD to Evaluate ABL103 and KEYTRUDA® Combo in Advanced Solid Tumor Clinical Trial
ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, today announced that it has entered into a clinical trial collaboration ...
October 07, 2024 | News
Evonik Launches Global Competence Network to Advance Cell Culture-Based Therapies
First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...
October 03, 2024 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
